Cargando…
A Bispecific Antibody to Link a TRAIL-Based Antitumor Approach to Immunotherapy
T-cell-based immunotherapy strategies have profoundly improved the clinical management of several solid tumors and hematological malignancies. A recently developed and promising immunotherapy approach is to redirect polyclonal MHC-unrestricted T lymphocytes toward cancer cells by bispecific antibodi...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823250/ https://www.ncbi.nlm.nih.gov/pubmed/31708930 http://dx.doi.org/10.3389/fimmu.2019.02514 |